http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021109549-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08dde60e3e0ca1e6ffaa5143e5c8477a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65 |
| filingDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_434fca650efaa57d3da252e39c556036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1dd19caffac46471d08b56375144ea1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29daa4583cd9604fdc2557809351388c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_912b613632aa2ea07b626ac78bce7dc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_582a6f9c68ecfd4d7a11f784d0d4ce53 |
| publicationDate | 2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021109549-A1 |
| titleOfInvention | Joint application of quercetin and antibacterial medicament |
| abstract | A joint application of quercetin and an antibacterial medicament, capable of generating synergistic antibacterial efficacy, and reducing the minimum inhibitory concentration and minimum bactericidal concentration of the antibacterial medicament. The joint medicament is capable inhibiting bacterial growth; meanwhile, as quercetin provides a synergistic effect against Escherichia coli as the antibacterial medicament, the antibacterial medicament inhibits at a reduced dosage the growth of pathogenic bacteria, thus enhancing the antibacterial efficacy of the antibacterial medicament, also reducing the generation of drug resistance in bacteria, enhancing the effect of bacterial infection resistance, reducing the dosage of the antibacterial medicament used, and allowing the compound or the combination to be applied in preventing and treating diseases caused by bacterial infections. |
| priorityDate | 2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.